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Résumé en
anglais
Nonalcoholic fatty liver disease (NAFLD) has become a major public health issue. The
goal of this study was to assess the clinical use of liver stiffness measurement (LSM)
evaluated by supersonic shear imaging (SSI), FibroScan, and acoustic radiation force
impulse (ARFI) in a cohort of NAFLD patients who underwent liver biopsy. A total of
291 NAFLD patients were prospectively enrolled from November 2011 to February
2015 at 2 French university hospitals. LSM was assessed by SSI, FibroScan (M
probe), and ARFI within two weeks prior to liver biopsy. Calculations of the area
under the receiver operating curve (AUROC) were performed and compared for the
staging of liver fibrosis. AUROC for SSI, FibroScan, and ARFI were 0.86, 0.82, and
0.77 for diagnoses of ≥F2; 0.89, 0.86, and 0.84 for ≥F3; and 0.88, 0.87, and 0.84 for
F4, respectively. SSI had a higher accuracy than ARFI for diagnoses of significant
fibrosis (≥F2) (P = 0.004). Clinical factors related to obesity such as body mass index
≥ 30 kg/m(2) , waist circumference ≥102 cm or increased parietal wall thickness were
associated with LSM failures when using SSI or FibroScan and with unreliable results
when using ARFI. In univariate analysis, FibroScan values were slightly correlated
with NAFLD activity score and steatosis (R = 0.28 and 0.22, respectively), whereas
SSI and ARFI were not; however, these components of NAFLD did not affect LSM
results in multivariate analysis. The cutoff values for SSI and FibroScan for staging
fibrosis with a sensitivity ≥90% were very close: 6.3/6.2 kPa for ≥F2, 8.3/8.2 kPa for
≥F3, and 10.5/9.5 kPa for F4.
CONCLUSION: Although obesity is associated with an increase in LSM failure, the
studied techniques and especially SSI provide high value for the diagnosis of liver
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